A novel framework to estimate multidimensional minimum effective doses using asymmetric posterior gain and -tapering
From MaRDI portal
Publication:2170396
DOI10.1214/21-AOAS1549zbMATH Open1498.62200WikidataQ114060487 ScholiaQ114060487MaRDI QIDQ2170396FDOQ2170396
Authors: Thevaa Chandereng, Keith M. Diaz, Ying Kuen Cheung
Publication date: 5 September 2022
Published in: The Annals of Applied Statistics (Search for Journal in Brave)
Recommendations
- A hybrid method to estimate the minimum effective dose for monotone and non-monotone dose-response relationships
- Simultaneous identifications of the minimum effective dose in each of several groups
- Step Contrasts for Identifying the Minimum Effective Dose
- NONPARAMETRIC IDENTIFICATION OF THE MINIMUM EFFECTIVE DOSE FOR RANDOMIZED BLOCK DESIGNS
- Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates
Cites Work
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
- Dose-finding with two agents in phase I oncology trials
- A hierarchical Bayesian design for phase I trials of novel combinations of cancer therapeutic agents
- Sequential Implementation of Stepwise Procedures for Identifying the Maximum Tolerated Dose
- Continual reassessment method for partial ordering
This page was built for publication: A novel framework to estimate multidimensional minimum effective doses using asymmetric posterior gain and \(\epsilon\)-tapering
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2170396)